M1RN34.SA Moderna Inc

Healthcare Biotechnology Sao Paulo Exchange
71.14 BRL
Close of Nov 5, 2026
6.02 71.14
Market cap
BRL 568B
P/E
-
P/B
13.68x
ROE
-62.9%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is M1RN34.SA undervalued?

Graham number

The Graham number of Moderna Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Moderna Inc fundamental analysis

No fundamental analysis for Moderna Inc yet.

Moderna Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Moderna Inc

Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines;…

Full company profile